Health Care & Life Sciences » Pharmaceuticals | Assembly Biosciences Inc.

Assembly Biosciences Inc.

Assembly Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.25
Market Cap
$375.07 M
Shares Outstanding
25.55 M
Public Float
22.35 M

Profile

Address
11711 North Meridian Street
Carmel Indiana 46032
United States
Employees -
Website http://www.assemblybio.com
Updated 07/08/2019
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

Financials

View All
Created with Highcharts 5.0.14Assembly Biosciences Inc.Net Income. Fiscal year is January-December. All values USD Thousands.19 40319 40323 78823 78828 45328 45344 26144 26142 80842 80890 75190 751201320142015201620172018025k50k75k100k
Created with Highcharts 5.0.14Assembly Biosciences Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.000000009 0189 01814 80414 80420132014201520162017201802.5k5k7.5k10k12.5k15k17.5k

Derek A. Small
President, Chief Executive Officer & Director
Bill R. Ringo
Non-Executive Chairman